RU2011143156A - METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS - Google Patents

METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS Download PDF

Info

Publication number
RU2011143156A
RU2011143156A RU2011143156/14A RU2011143156A RU2011143156A RU 2011143156 A RU2011143156 A RU 2011143156A RU 2011143156/14 A RU2011143156/14 A RU 2011143156/14A RU 2011143156 A RU2011143156 A RU 2011143156A RU 2011143156 A RU2011143156 A RU 2011143156A
Authority
RU
Russia
Prior art keywords
colorectal cancer
carcinomatosis
complicated
cancer forms
perfusion
Prior art date
Application number
RU2011143156/14A
Other languages
Russian (ru)
Inventor
Алексей Михайлович Беляев
Александр Анатольевич Захаренко
Сергей Александрович Кондрацов
Дмитрий Александрович Суров
Олег Владимирович Бабков
Original Assignee
Федеральное государственное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова (ВМедА) Министерства обороны Российской Федерации
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова (ВМедА) Министерства обороны Российской Федерации filed Critical Федеральное государственное военное образовательное учреждение высшего профессионального образования Военно-медицинская академия им. С.М. Кирова (ВМедА) Министерства обороны Российской Федерации
Priority to RU2011143156/14A priority Critical patent/RU2011143156A/en
Publication of RU2011143156A publication Critical patent/RU2011143156A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Способ профилактики карциноматоза брюшины при осложненных формах колоректального рака путем проведения регионарной химиогипертермической перфузии, отличающийся тем, что перфузию проводят во время неотложного оперативного вмешательства в течение 30 мин, при температуре перфузата 43°С, дозировка цисплатина 150 мг/м.A method for the prevention of peritoneal carcinomatosis in complicated forms of colorectal cancer by performing regional chemohyperthermic perfusion, characterized in that the perfusion is carried out during an emergency surgery for 30 minutes, at a perfusate temperature of 43 ° C, the dosage of cisplatin is 150 mg / m.

Claims (1)

Способ профилактики карциноматоза брюшины при осложненных формах колоректального рака путем проведения регионарной химиогипертермической перфузии, отличающийся тем, что перфузию проводят во время неотложного оперативного вмешательства в течение 30 мин, при температуре перфузата 43°С, дозировка цисплатина 150 мг/м2. A method for the prevention of peritoneal carcinomatosis in complicated forms of colorectal cancer by conducting regional chemohyperthermic perfusion, characterized in that the perfusion is carried out during an emergency surgery for 30 minutes, at a perfusate temperature of 43 ° C, the dosage of cisplatin is 150 mg / m 2 .
RU2011143156/14A 2011-10-25 2011-10-25 METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS RU2011143156A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2011143156/14A RU2011143156A (en) 2011-10-25 2011-10-25 METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2011143156/14A RU2011143156A (en) 2011-10-25 2011-10-25 METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS

Publications (1)

Publication Number Publication Date
RU2011143156A true RU2011143156A (en) 2013-04-27

Family

ID=49152101

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011143156/14A RU2011143156A (en) 2011-10-25 2011-10-25 METHOD FOR PREVENTING PITCH CARCINOMATOSIS IN COMPLICATED COLORECTAL CANCER FORMS

Country Status (1)

Country Link
RU (1) RU2011143156A (en)

Similar Documents

Publication Publication Date Title
PH12015500513A1 (en) Methods for the treatment of locally advanced breast cancer
EA201591612A1 (en) APPLICATION OF PYRAZOLPYRIMIDIN DERIVATIVES FOR THE TREATMENT OF VIOLATIONS ASSOCIATED WITH PI3Kδ
CR20120448A (en) HETEROCYCLIC COMPOUND
MX2015011753A (en) Methods of treating bladder cancer.
MX2015017201A (en) Pyrazolopyridine derivatives for use in the treatment of bladder cancer.
EA201400178A1 (en) BREAST CANCER TREATMENT
CO6620019A2 (en) Bladder cander treatment methods
CY1122805T1 (en) COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
PH12014502048B1 (en) Treatment of cancer with tor kinase inhibitors
MX2015011428A (en) Methods of treating and preventing cancer drug resistance.
EA201400119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND THEIR APPLICATION
PH12014502046A1 (en) Treatment of cancer with tor kinase inhibitors
BR112017006113A2 (en) synergistic combinations of auristatin
EA201591024A1 (en) DIMER CONNECTIONS
EA201591987A1 (en) TREATMENT OF MALIGNANT TUMOR DIHYDROPYRAZINOPIRASINS
MX2016001136A (en) Oxoquinazolinyl-butanamide derivatives.
MX2015014590A (en) Treatment of cancer with dihydropyrazino-pyrazines.
EA201301269A1 (en) METHOD OF TREATMENT OF PROGRESSIVE SOLID TUMORS
EA201790726A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ULCERAL COLITIS
EA201301265A1 (en) METHOD OF TREATMENT OF SOLIDAL MALIGNANT TUMORS, INCLUDING PROGRESSIVE OR METASTATIC SOLIDAL MALIGNANT TUMORS
UA111333C2 (en) Method for producing l-arginine salt of perindropryl
MX2015012444A (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens.
MX366140B (en) Piperidine urea derivatives.
UA112746C2 (en) Anti-Cancer Steroid Lactones Unsaturated in 7 (8)
MX2015012600A (en) Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl) methanone compounds as cancer cell growth inhibitors.